ITGAM and neoplasm: When assessing changes of the myeloid cell subpopulations in response to treatment, we observed that addition of single-agent mTGF-β-TRAP did not affect the percentage of monocytes/macrophages (Figure 3B), granulocytes (Figure 3C), or M-MDSCs (Supplemental Figure 5E) among CD45+CD11b+ cells in either KPC tumor type.